Subscribe to RSS
DOI: 10.1055/s-0030-1258168
Ultrasound-Promoted Formation of Isopentenyl Alcohol Dianion: Straightforward Synthesis of Perhydrofuro[2,3-b]furans
Dedicated to the memory of Professor José Manuel Concellón
Publication History
Publication Date:
12 July 2010 (online)
Abstract
Ultrasound has been found to accelerate the formation of isopentenyl alcohol dianion by metalation with butyllithium in diethyl ether-tetrahydrofuran. The reaction of this dianion with carbonyl compounds followed by intramolecular acetalization under Wacker-type conditions provides a direct route for the synthesis of 2-substituted perhydrofuro[2,3-b]furans.
Key words
metalation - ultrasound - polyanions - Wacker-type reaction - cyclization - perhydrofuro[2,3-b]furans
2-Methylprop-2-en-1-ol (methallyl alcohol, 1) and 3-methylbut-3-en-1-ol (isopentenyl alcohol, 2) are inexpensive and commercially available building blocks, which, through a double direct metalation reaction, can be readily transformed into synthetically useful molecules (Figure [¹] ). The formation of dianions 4 and 5 from 1 and 2 was first described in the 1970s using, respectively, Schlosser’s base in hexane or butyllithium/TMEDA in hexane. [¹] A modification of the latter procedure was later introduced by Trost et al. by using a diethyl ether-tetrahydrofuran solvent mixture and optimized for the preparation of allylsilanes derived from 1 and 2. [²] In more recent literature, the direct trimetalation of 2,4-dimethylpenta-1,4-dien-3-ol (3) was conducted with sec-butyllithium/TMEDA in diethyl ether-cyclohexane, with the derived organolithium intermediate 6 being trapped with various electrophiles. [³]

Figure 1
Perhydrofuro[2,3-b]furans substituted at the 2-position can be found as substructures in clerodane diterpenes, which are especially abundant in Ajuga [4] and Scutellaria [5] species. Some representative examples of this family of natural products are lupulin C [4a] (I) and scutecolumnin C (II) [5a] (Figure [²] ). In some cases, a perhydrofuro[2,3-b]furan-2-one moiety is also present in the clerodanes, arising from the oxidation of the hemiacetal functionality, i.e. III. [6] These compounds exhibit manifold biological activity, especially as antifeedants of insects. [7] Model compounds IV and V are synthetic analogues that were found to display insect antifeedant activity in laboratory bioassays [8] (Figure [²] ). In addition, compound V (R = Me) is a key intermediate in the synthesis of artificial analogues of mycalamide A. [9] The reported synthetic routes to compounds of the type IV and V are, however, rather long. [8-¹0] Alternative approaches to obtain 2-substituted perhydrofuro[2,3-b]furans in a more straightforward manner are, therefore, welcome.

Figure 2
Due to our continued interest in the synthesis of fused bicyclic [¹¹] and spirocyclic [¹²] polyether skeletons, we recently published a highly efficient synthesis of 2,5-substituted perhydrofuro[2,3-b]furans. The strategy was based on the arene-catalyzed lithiation of allylic chlorinated substrates and subsequent reaction with carbonyl compounds, followed by intramolecular acetalization of the resulting 3-methylene-1,5-diols under Wacker-type reaction conditions. [¹³] The latter step represents the first palladium-catalyzed intramolecular acetalization of a dihydroxy-substituted geminal alkene (Scheme [¹] ).

Scheme 1 Synthesis of 2,5-substituted perhydrofuro[2,3-b]furans through arene-catalyzed lithiation and Wacker-type reactions
We wish to present herein a new and direct route for the synthesis of 2-substituted perhydrofuro[2,3-b]furans involving the generation of isopentenyl alcohol dianion under ultrasound irradiation and intramolecular cyclization under Wacker-type reaction conditions. A protocol for the direct oxidation of the perhydrofuro[2,3-b]furan moiety to the corresponding lactone has been also studied.
Initial attempts to obtain the precursor diols following a similar strategy to the aforementioned route was rather long and, therefore, not very efficient (Scheme [²] ). The whole process involved protection of isopentenyl alcohol, allylic chlorination, [¹4] arene-catalyzed lithiation [¹5] in the presence of a carbonyl compound, and deprotection. Instead, we decided to use isopentenyl alcohol (2) as the direct source of dianion 5 and study its reactivity with carbonyl compounds. The reaction of methallyl alcohol dianion 4 with ketones was described by Carlson, [¹b] although the yields of the corresponding diols were modest (15-40%). The reactivity of trianion 6 was not tested with carbonyl compounds [³] whereas that of dianion 5 was mainly reported with chlorosilanes [²] and allyl [¹a] and alkyl halides. [¹6] To the best of our knowledge, there is only one example in the literature of the reaction of dianion 5 with carbonyl compounds (two aldehydes), as the key step in the synthesis of vitamin A and methyl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate. [¹7] Therefore, it would be of interest to study the generation and reactivity of dianion 5 with carbonyl compounds in more detail.

Scheme 2 Preliminary synthesis of a 3-methylene-1,5-diol precursor of a 2-substituted perhydrofuro[2,3-b]furan
We first tested the reaction conditions as reported by Trost et al. for the synthesis of allylsilanes 7 and 8 from 1 and 2; they were both obtained in 52% isolated yield (Scheme [³] ). [²] The only objection to this methodology is the long reaction time required for the generation of the corresponding dianions 4 and 5, respectively. We observed, however, that the reaction times were notably shortened under ultrasound irradiation [¹8] whilst maintaining the product yields (Scheme [4] ).

Scheme 3 Synthesis of allylsilanes 7 and 8 through conventional metalation conditions

Scheme 4 Synthesis of allylsilanes 7 and 8 through ultrasound-promoted dianion formation
Based on this methodology, a variety of reaction conditions were screened in order to optimize both the dianion formation of 2 and its reactivity toward carbonyl compounds, using pentan-3-one as the model electrophile (Table [¹] ). Within the different experiments performed with 10 M butyllithium in diethyl ether-tetrahydrofuran and TMEDA at room temperature (entries 1-5), the best results were obtained using 5.2 equivalents of TMEDA and 3.0 equivalents of pentan-3-one (entry 4). The slow addition of the electrophile at -78 ˚C (entry 5), however, minimized the formation of byproducts when carbonyl compounds other than pentan-3-one were used, especially, aldehydes. Different reaction conditions reported in the literature, some of which for polyanion formation and reaction with some other electrophiles, gave poorer yields and/or complex mixtures. Such is the case for butyllithium in diethyl ether-TMEDA (entry 6), [¹6] toluene (entry 7), [¹9] or hexane-TMEDA (entry 8); [¹7] sec-butyllithium in diethyl ether-cyclohexane-TMEDA (entry 9), [³] tert-butyllithium in diethyl ether-tetrahydrofuran-TMEDA (entry 10) or the dianion resulting from the reductive cleavage of tetrahydrofuran with lithium 4,4′-di-tert-butylbiphenyl (Li-DTBB) (entry 11). [²0]
![]() | |||||||||||||||||||
Entry | Base (equiv) | Solvent, conditions | Additive (equiv) | Equiv of Et2CO | Yieldb (%) | ||||||||||||||
1 | 10 M BuLi (3.0) | Et2O-THF (3:2), MW | TMEDA (2.6) | 1.0 | 35 | ||||||||||||||
2 | 10 M BuLi (3.0) | Et2O-THF (3:2), MW | TMEDA (2.6) | 2.0 | 44 | ||||||||||||||
3 | 10 M BuLi (3.0) | Et2O-THF (3:2), MW | TMEDA (5.2) | 2.0 | 48 | ||||||||||||||
4 | 10 M BuLi (3.0) | Et2O-THF (3:2), MW | TMEDA (5.2) | 3.0 | 58 | ||||||||||||||
5 | 10 M BuLi (3.0) | Et2O-THF (3:2), MW | TMEDA (5.2) | 3.0c | 58 | ||||||||||||||
6 [¹6] | 2 M BuLi (2.0) | Et2O | TMEDA (2.6) | 0.5 | complex mixture | ||||||||||||||
7 [¹9] | 10 M BuLi (3.0) | toluene, MW | - | 1.0 | 24 | ||||||||||||||
8 [¹7] | 2.5 M BuLi (2.0) | hexane | TMEDA (2.0) | 1.0 | 37 | ||||||||||||||
9 [³] | 1.4 M s-BuLi (4.7) | Et2O-cyclohexane (3:2) | TMEDA (5.3) | 3.0 | complex mixture | ||||||||||||||
10 | 1.7 M t-BuLi (3.0) | Et2O-THF (3:2), MW | TMEDA (5.2) | 3.0 | complex mixture | ||||||||||||||
11 [²0] | Li(CH2)4OLid (3.5) | THF, MW | - | 1.0 | 23 | ||||||||||||||
| |||||||||||||||||||
a Dianion
formation at r.t. for 6 h (12 h in entry 8, 4 h in entry 9), followed
by reaction with pentan-3-one at -78 ˚C to r.t.
overnight. b Isolated yield after column chromatography. c Slow addition of the ketone (-78 ˚C for 3 h), overnight at -78 ˚C to r.t. d Generated from THF and Li-DTBB. [²0] |
The optimized reaction conditions were extended to other carbonyl compounds, including three different ketones and aldehydes bearing alkyl, cycloalkyl, and aryl substituents (Scheme [5] , Table [²] ). Within the ketones, pentan-3-one gave the best result (entry 1), with the methylene diols 9b and 9c derived from cyclohexanone and benzophenone, respectively, being obtained in modest yields (entries 2 and 3). A similar performance was observed for valeraldehyde, cyclohexanecarbaldehyde, and benzaldehyde, which gave 9d-f in 32-66% yield (entries 3-6). Notwithstanding the low yields, the fact that the reaction could be carried on a 10-mmol scale allowed the methylene diols 9 to be obtained in substantial and practical amounts.

Scheme 5 Reaction of isopentenyl alcohol dianion with various carbonyl compounds
Diols 9 were subjected to intramolecular acetalization under Wacker-type reaction conditions as previously described by us (Scheme [6] , Table [²] ). [¹³] The diols derived from pentan-3-one 9a and cyclohexanone 9b cyclized nicely to afford the corresponding perhydrofuro[2,3-b]furans 10a and 10b in high yields (entries 1 and 2). In contrast, diol 8c derived from benzophenone gave the product 10c in modest yield (entry 3). Acetalization of diols derived from aldehydes 9d-f proceeded stereoselectively in modest-to-moderate isolated yields (entries 4-6). A maximum 93:7 diastereromeric ratio was reached in the acetalization of the diol derived from cyclohexanecarbaldehyde 9e (entry 5). The major (2R*,3aR*,6aS*) relative configuration observed is in agreement with that previously reported by us for 2,5-substituted perhydrofuro[2,3-b]furans [¹³] and was confirmed by NOE experiments conducted on both diastereomers of compound 10f (Figure [³] ). A small NOE was observed for H2 and H3a in both diastereomers, whereas NOE between H2 and H5 was manifested only in the major diastereomer. PM3 [²¹] geometry optimization revealed the closer location of H2 and H5 in (2R*,3aS*,6aR*)-10f compared with that in (2S*,3aS*,6aR*)-10f (Figure [³] ). It is noteworthy that quantitative conversion of the starting methylene diols was recorded in all cases. An important loss of mass, however, was observed for compounds 10c,d during their purification by column chromatography, probably due to partial decomposition. The general longer reaction times required for the formation of 2-substituted or 2,2-disubstituted compounds 10 (24 h) in comparison with the 2,5-disubstituted or 2,2,5,5-tetrasubstituted counterparts (8 h) [¹³] could be attributed somewhat to the gem-dialkyl effect. [²²]

Scheme 6 Cyclization of methylene diols 9 to perhydrofuro[2,3-b]furans 10 under Wacker-type conditions

Figure 3 NOE experiments and optimized geometry models for the diastereomeric perhydrofuro[2,3-b]furans 10f; numbers on the arrows refer to interatomic distances in Å
In spite of the fact that the overall yields for compounds 10 are not as optimum as desired, the methodology presented herein is the most direct route reported so far to this type of compounds. As an example, the synthesis of perhydrofuro[2,3-b]furan 10e described by de Groot et al. [8b] involved the noncommercial 4,4-diethoxybutanenitrile and 2-cyclohexyloxirane starting materials in a nine-step sequence. In contrast, only two steps, from commercially available isopentenyl alcohol and cyclohexanecarbaldehyde, were involved in our methodology, which, in addition, resulted in a higher product stereoselectivity (Scheme [7] ).

Scheme 7 Comparative synthesis of perhydrofuro[2,3-b]furan 10e according to the literature approach [8b] and that described herein
Finally, we studied the possibility to access the perhydrofuro[2,3-b]furan-2-one moiety by direct oxidation of the perhydrofuro[2,3-b]furan core of 10a. Among the different conditions tested, the oxidation with catalytic ruthenium(IV) oxide and stoichiometric sodium periodate in the dichloromethane-water-acetonitrile solvent system gave the best outcome of lactone 11a (Scheme [8] ). [²³]

Scheme 8 Oxidation of perhydrofuro[2,3-b]furan 10a to lactone 11a
In conclusion, we have developed a new synthesis of 2-substituted perhydrofuro[2,3-b]furans based on the ultrasound-promoted generation of the dianion of isopentenyl alcohol and reaction with carbonyl compounds, followed by palladium-catalyzed intramolecular acetalization under Wacker-type reaction conditions. The methodology has been applied both to ketones and aldehydes, with the perhydrofuro[2,3-b]furans arising from the latter being obtained stereoselectively. Although the overall yields are modest, this approach represents the most direct route to this kind of compounds. Moreover, their transformation into the corresponding lactones can be easily accomplished by ruthenium-catalyzed oxidation. Further studies regarding the reactivity of these compounds are underway.
Melting points were obtained with a Reichert Thermovar apparatus. IR analysis was performed with a FT-IR Nicolet Impact 400D spectrophotometer. NMR spectra were recorded on 300 and 400 spectrometers [300 and 400 MHz (¹H) and 75 and 100 MHz (¹³C)] using CDCl3 as solvent and TMS as internal standard. Mass spectra (EI) were obtained at 70 eV on an Agilent 5973 spectrometer. HRMS analyses were carried out on a Finnigan MAT95S spectrometer. The purity of volatile compounds and the chromatographic analyses (GLC) were determined with a Hewlett Packard HP-6890 instrument equipped with a flame ionization detector and a 30 m capillary column (0.32 mm diameter, 0.25 µm film thickness), using N2 (2 mL/min) as carrier gas, T injector = 275 ˚C, T column = 60 ˚C (3 min) and 60-270 ˚C (15 ˚C/min). Sonication was carried out on a JP Selecta Ultrasons apparatus (6 L, 150 W, 40 kHz). Flash column chromatography was performed using silica gel 60 (40-60 µ). Methallyl alcohol (Aldrich), isopentenyl alcohol (Aldrich), 10 M BuLi (Aldrich), TMEDA (Alfa Aesar), anhyd Et2O (Fluka, 99.8%, H2O ≤0.005%), the carbonyl compounds (Aldrich, Alfa Aesar), PdCl2 (Merck), CuCl2 (Aldrich), 35% H2O2 (Acros), MeOH (Panreac), RuO2˙xH2O (Aldrich), NaIO4 (Riedel de Häen), CH2Cl2 (Panreac), and MeCN (Panreac) are commercially available. THF was dried in a Sharlab PS-400-3MD solvent purification system using an alumina column.
Synthesis of Allylsilanes 7 and 8 and Methylene-1,5-diols 9; General Procedure
Methallyl alcohol (1, 0.84 mL, 10 mmol) or 3-methylbut-3-enol (2, 1 mL, 10 mmol) was added dropwise to a soln of 10 M n-BuLi (3 mL, 30 mmol) in anhyd Et2O (12 mL) and anhyd TMEDA (8 mL) at 0 ˚C under an inert atmosphere. Then, anhyd THF (8 mL) was added to the mixture and it was stirred at 0 ˚C for a few min. The flask content was sonicated for 6 h with formation of a deep red precipitate attributed to the corresponding dianions. Next, the corresponding electrophile (30 mmol) in anhyd Et2O (5 mL) was slowly added (for allylsilanes slow addition was not required) at -78 ˚C over 3 h and the mixture was stirred for an additional 12 h (15 min for allylsilanes) and the temperature was allowed to reach r.t. The reaction was quenched with H2O (10 mL), acidified with 3 M HCl, and extracted with Et2O (3 × 40 mL). The resulting combined organic phases were sequentially washed with sat. CuSO4 soln (2 × 10 mL, in order to quench the TMEDA) and H2O (2 × 10 mL). The new organic phase was dried (anhyd MgSO4) and the solvent was evaporated (20 mbar) to give a crude product that was purified by column chromatography (silica gel, hexane-EtOAc). The allylsilanes 7 and 8 were characterized by comparison of their physical and spectroscopic data with those reported in the literature. [²] New compounds 9 are as given below.
5-Ethyl-3-methyleneheptane-1,5-diol (9a)
Colorless oil; GLC: t R = 10.28 min; R f = 0.33 (hexane-EtOAc, 1:1).
IR (film): 3362 (OH), 3073, 1638 cm-¹ (CH=C).
¹H NMR (300 MHz, CDCl3): δ = 0.87 (t, J = 7.6 Hz, 6 H, 2 CH3), 1.50 (q, J = 7.6 Hz, 4 H, 2 CH 2CH3), 2.23 (br s, 2 H, 2 OH), 2.43 (t, J = 5.9 Hz, 2 H, CH 2CH2OH), 3.75 (t, J = 5.9 Hz, 2 H, CH2CH 2OH), 4.91, 5.00 (2 s, 2 H, H2C=C).
¹³C NMR (75 MHz, CDCl3): δ = 8.0 (2 CH3), 30.9 (2 CH2CH3), 40.4 (CH2CH2OH), 44.2 (CH2COH), 61.2 (CH2OH), 75.0 (COH), 116.0 (H2 C=C), 143.9 (C=CH2).
MS (EI): m/z (%) = 154 [M+ - H2O] (<1), 87 (100), 69 (26), 57 (60).
HRMS: m/z [M+] calcd for C10H20O2: 172.1463; m/z [M+ - H2O] calcd for C10H18O: 154.1358; found: 154.1376.
1-(4-Hydroxy-2-methylenebutyl)cyclohexanol (9b)
White solid; mp 55 ˚C; GLC: t R = 11.90 min; R f = 0.44 (hexane-EtOAc, 1:1).
IR (KBr): 3415 (OH), 3076, 1638 cm-¹ (CH=C).
¹H NMR (300 MHz, CDCl3): δ = 1.20-1.70 [m, 10 H, (CH2)5], 2.24 (s, 2 H, CCH 2COH), 2.42 (t, J = 6.1 Hz, 2 H, CH 2CH2OH), 2.51 (br s, 2 H, 2 OH), 3.75 (t, J = 6.1 Hz, 2 H, CH2CH 2OH), 4.91, 5.00 (2 s, 2 H, H2C=C).
¹³C NMR (75 MHz, CDCl3): δ = 22.2 (2 CH2CH2COH), 25.6 (CH2CH2CH2COH), 37.8 (2 CH2COH), 40.5 (CH2CH2OH), 47.7 (CH2COH), 61.08 (CH2OH), 71.5 (COH), 115.9 (H2 C=C), 143.4 (C=CH2).
MS (EI): m/z (%) = 166 [M+ - H2O] (2), 100 (10), 99 (100), 81 (59), 79 (11), 55 (18).
HRMS: m/z [M+] calcd for C11H20O2: 184.1463; m/z [M+ - H2O] calcd for C11H18O: 166.1358; found: 166.1352.
3-Methylene-1,1-diphenylpentane-1,5-diol (9c)
Colorless oil; GLC: t R = 16.70 min; R f = 0.61 (hexane-EtOAc, 1:1).
IR (film): 3382 (OH), 3059, 3025, 1644, 1493 cm-¹ (CH=C).
¹H NMR (400 MHz, CDCl3): δ = 1.94 (t, J = 6.1 Hz, 2 H, CH 2CH2OH), 3.13 (s, 2 H, CH 2COH), 3.78 (t, J = 6.1 Hz, 2 H, CH 2OH), 4.82, 4.96 (2 s, 2 H, H2C=C), 7.15-7.55 (m, 10 H, 10 ArH).
¹³C NMR (100 MHz, CDCl3): δ = 39.8 (CH2CH2OH), 47.5 (CH2COH), 60.7 (CH2OH), 76.8 (COH), 117.8 (H2 C=C), 125.9, 126.8, 128.0 (10 ArCH), 142.4 (2 ArC), 146.8 (C=CH2).
MS (EI): m/z (%) = 250 [M+ - H2O,] (29), 232 (10), 220 (18), 217 (16), 206 (14), 205 (54), 204 (22), 203 (23), 202 (20), 184 (12), 183 (84), 182 (24), 178 (11), 165 (13), 128 (10), 105 (100), 91 (10), 77 (49), 51 (10).
HRMS: m/z [M+] calcd for C18H20O2: 268.1463; m/z [M+ - H2O] calcd for C18H18O: 250.1358; found: 250.1348.
3-Methylenenonane-1,5-diol (9d)
Colorless oil; GLC: t R = 10.65 min; R f = 0.33 (hexane-EtOAc, 1:1).
IR (film): 3345 (OH), 3075, 1644 cm-¹ (CH=C).
¹H NMR (400 MHz, CDCl3): δ = 0.92 (t, J = 7.0 Hz, 3 H, CH3), 1.20-1.55 [m, 6 H, (CH2)3], 1.96 (br s, 2 H, 2 OH), 2.10 (dd, J = 9.8, 6.9 Hz, 1 H, CH AHBCHOH), 2.25-2.40 (m, 3 H, CH 2CH2OH, CHA H BCHOH), 3.65-3.85 (m, 3 H, CHOH, CH 2OH), 4.99 (s, 2 H, H2C=C).
¹³C NMR (100 MHz, CDCl3): δ = 14.1 (CH3), 22.7, 27.9 (CH2 CH2CH3), 37.0 (CH2 CH2CHOH), 38.9 (CH2CH2OH), 44.1 (CCH2CHOH), 60.64 (CH2OH), 69.6 (CHOH), 114.8 (H2 C=C), 143.6 (C=CH2).
MS (EI): m/z (%) = 172 [M+] (<1), 154 [M+ - H2O] (2), 117 (25), 87 (65), 85 (12), 69 (100), 68 (68), 67 (50), 57 (19), 56 (32), 55 (11), 53 (11).
HRMS: m/z [M+] calcd for C10H20O2: 172.1463; m/z [M+ - H2O] calcd for C10H18O: 154.1358; found: 154.1351.
1-Cyclohexyl-3-methylenepentane-1,5-diol (9e)
Colorless oil; GLC: t R = 12.96 min; R f = 0.33 (hexane-EtOAc, 1:1).
IR (KBr): 3354 (OH), 3075, 1644 cm-¹ (CH2=C).
¹H NMR (300 MHz, CDCl3): δ = 0.85-1.48, 1.62-1.91 [2 m, 11 H, (CH2)5CH], 1.92-2.15, 2.26-2.40 (2 m, 6 H, 2 OH, CH2CCH2), 3.51 (ddd, J = 10.3, 5.6, 2.9 Hz, 1 H, CHOH), 3.75 (t, J = 6.2 Hz, 2 H, CH 2OH), 5.00 (s, 2 H, H2C=C).
¹³C NMR (75 MHz, CDCl3): δ = 26.1, 26.2, 26.5, 28.2, 29.0 [(CH2)5], 38.9 (CH2CH2OH), 40.8 (CH2CHOH), 43.6 (CHCOH), 60.6 (CH2OH), 73.5 (CHOH), 114.7 (H2 C=C), 144.0 (C=CH2).
MS (EI): m/z (%) = 180 [M+ - H2O] (<1%), 143 (11), 113 (44), 95 (100), 83 (26), 69 (15), 68 (27), 67 (28), 56 (11), 55 (30).
HRMS: m/z [M+] calcd for C12H22O2: 198.1620; m/z [M+ - H2O] calcd for C12H20O: 180.1514; found: 180.1531.
3-Methylene-1-phenylpentane-1,5-diol (9f)
Colorless oil; GLC: t R = 13.07 min; R f = 0.33 (hexane-EtOAc, 1:1).
IR (KBr): 3354 (OH), 3064, 3029, 1644, 1494 cm-¹ (CH=C).
¹H NMR (300 MHz, CDCl3): δ = 2.25-2.57 (m, 4 H, CH2CCH2), 3.78 (t, J = 5.9 Hz, 2 H, CH 2OH), 4.75-4.90 (m, 1 H, CHOH), 5.04, 5.05 (2 s, 2 H, H2C=C), 7.20-7.45 (m, 5 H, 5 ArH).
¹³C NMR (75 MHz, CDCl3): δ = 39.0 (CH2CH2OH), 46.1 (CH2CHOH), 60.6 (CH2OH), 72.5 (CHOH), 115.4 (H2 C=C), 125.7, 127.6, 128.5 (5 ArH), 143.1 (ArC), 144.0 (C=CH2).
MS (EI): m/z (%) = 192 [M+] (<1), 174 [M+ - H2O] (4), 129 (10), 107 (100), 105 (14), 79 (45), 77 (30).
HRMS: m/z [M+] calcd for C12H16O2: 192.1150; m/z [M+ - H2O] calcd for C12H14O: 174.1045; found: 174.101.
Palladium-Catalyzed Cyclization of the Methylene-1,5-diols 9; General Procedure
A soln of PdCl2 (8.9 mg, 0.05 mmol), CuCl2 (67.2 mg), MeOH (10 mL), and the corresponding methylene-1,5-diol 9 (1 mmol) was prepared in a screw-top tube, followed by the addition of 35% H2O2 soln (0.86 mL, 10 mmol). The top was airtight on the reaction tube, which was heated at 70 ˚C for 24 h. The solvent was evaporated to dryness, followed by the addition of EtOAc (20 mL) and filtration through Celite. The filtrate was washed with brine (2 × 5 mL), the organic phase was dried (anhyd MgSO4), and the solvent evaporated under vacuum (20 mbar). Compounds 10a and 10b did not require any further purification, while compounds 10c-f were purified by column chromatography (silica gel, hexane-EtOAc).
(3a R *,6a S *)-2,2-Diethylhexahydrofuro[2,3- b ]furan (10a)
Colorless oil; GLC: t R = 9.28 min; R f = 0.48 (hexane-EtOAc, 8:2).
IR (film): 1024 cm-¹ (C-O).
¹H NMR (400 MHz, CDCl3): δ = 0.85, 0.90 (2 t, J = 7.5 Hz, 6 H, 2 CH3), 1.35-1.75, 1.88-2.07 (2 m, 8 H, 2 CH 2CH3, CH 2CHCH 2), 2.85-3.00 (m, 1 H, CH2CHCH 2), 3.84-3.95 (m, 2 H, CH2O), 5.68 (d, J = 5.1 Hz, 1 H, OCHO).
¹³C NMR (100 MHz, CDCl3): δ = 8.4, 8.7 (2 CH3), 30.5, 31.2 (2 CH2CH3), 32.8 (CH2CH2CO), 39.2 (CHCH2COC), 43.1 (CH2 CHCH2), 65.8 (CH2O), 88.0 (CO), 109.1 (OCHO).
MS (EI): m/z (%) = 170 [M+] (<1), 141 (100), 95 (20), 57 (55), 55 (15).
HRMS: m/z [M+] calcd for C10H18O2: 170.1307; m/z (M+ - C2H5) calcd for C8H13O2: 141.0910; found: 141.0899.
(3a′ R *,6a′ S *)-Tetrahydro-3′ H -spiro[cyclohexane-1,2′-furo[2,3- b ]furan] (10b)
Colorless oil; GLC: t R = 11.02 min; R f = 0.40 (hexane-EtOAc, 8:2).
IR (KBr): 1020 cm-¹ (C-O).
¹H NMR (300 MHz, CDCl3): δ = 1.20-1.80, 1.85-2.14 (2 m, 14 H, 7 CH2), 2.85-3.01 (m, 1 H, CH2CHCH2), 3.80-4.00 (m, 2 H, CH2O), 5.68 (d, J = 5.2 Hz, 1 H, OCHO).
¹³C NMR (75 MHz, CDCl3): δ = 23.3, 23.7, 25.4 [2 CH2CH2C, CH2(CH2)2C], 32.5 (CH2CH2O), 36.9, 38.1 (2 CH2 CH2C), 41.2 (CCH2CH), 42.4 (CH2 CHCH2), 65.6 (CH2O), 84.3 (CO), 108.4 (OCHO).
MS (EI): m/z (%) = 182 [M+] (20), 140 (19), 139 (100), 126 (30), 121 (11), 84 (10), 82 (25), 81 (13), 67 (11), 55 (23).
HRMS: m/z [M+] calcd for C11H18O2: 182.1307; found: 182.1332.
(3a R *,6a S *)-2,2-Diphenylhexahydrofuro[2,3- b ]furan (10c)
White solid; mp 95 ˚C; GLC: t R = 16.46 min; R f = 0.46 (hexane-EtOAc, 8:2).
IR (KBr): 3053, 3021, 1595, 1490 (CH=C), 1011 cm-¹ (C-O).
¹H NMR (300 MHz, CDCl3): δ = 1.65 (dd, J = 6.2, 5.0 Hz, 1 H, CH AHBCH2O), 1.84-1.98 (m, 1 H, CHA H BCH2O), 2.15 (dd, J = 8.5, 6.3 Hz, 1 H, CH AHBC), 2.75-2.90 (m, 1 H, CH2CHCH2), 3.03 (dd, J = 8.7, 6.3 Hz, 1 H, CHA H BC), 3.75-3.85 (m, 1 H, CH AHBO), 3.93 (dd, J = 6.8, 5.7 Hz, 1 H, CHA H BO), 5.79 (d, J = 5.3 Hz, 1 H, OCHO), 7.10-7.60 (m, 10 H, 10 ArH).
¹³C NMR (75 MHz, CDCl3): δ = 31.9 (CH2CH2O), 42.7 (CH2C), 43.1 (CH2 CHCH2), 66.5 (CH2O), 88.6 (CO), 108.7 (OCHO), 125.4, 125.6, 126.8, 128.0, 128.2 (10 ArCH), 145.3, 145.9 (2 ArC).
MS (EI): m/z (%) = 266 [M+] (10), 190 (10), 189 (62), 184 (14), 183 (100), 178 (12), 165 (18), 115 (10), 105 (48), 91 (12), 84 (13), 77 (19).
HRMS: m/z [M+] calcd for C18H18O2: 266.1307; found: 266.1271.
(2 R *,3a R *,6a S *)-2-Butylhexahydrofuro[2,3- b ]furan (10d)
Colorless oil; GLC: t R = 10.70 min; R f = 0.50 (hexane-EtOAc, 8:2).
IR (KBr): 1015 cm-¹ (C-O).
¹H NMR (300 MHz, CDCl3): δ = 0.90 (t, J = 6.9 Hz, 3 H, CH3), 1.20-1.50 [m, 6 H, (CH2)3], 1.50-1.78, 1.78-1.90, 2.04-2.20 (3 m, 4 H, CH 2CHCH 2), 2.75-2.95 (m, 1 H, CH2CHCH2), 3.79-3.99 (m, 2 H, CH2O), 4.00-4.15 (m, 1 H, CHO), 5.71 (d, J = 5.1 Hz, 1 H, OCHO).
¹³C NMR (75 MHz, CDCl3): δ = 14.0 (CH3), 22.7, 28.3 (CH3 CH2 CH2), 32.7, 35.3, 38.8 (CH2CHCH2, CH3CH2CH2 CH2), 42.6 (CH2 CHCH2), 68.2 (CH2O), 79.7 (CHO), 108.9 (OCHO).
MS (EI): m/z (%) = 170 [M+] (<1), 113 (100), 84 (12), 69 (48), 67 (10), 55 (16).
HRMS: m/z [M+] calcd for C10H18O2: 170.1307; found: 170.1332.
Selected data for the minor diastereomer (2S*,3aR*,6aS*)-10d:
GLC: t R = 10.60 min.
¹H NMR (400 MHz, CDCl3): δ = 5.63 (d, J = 5.3 Hz, 1 H, OCHO).
MS (EI): m/z (%) = 170 [M+] (<1), 113 (100), 84 (15), 69 (47), 67 (11), 55 (17).
(2 R *,3a S *,6a R *)-2-Cyclohexylhexahydrofuro[2,3- b ]furan (10e) [8b]
Colorless oil; GLC: t R = 12.57 min; R f = 0.55 (hexane-EtOAc, 8:2).
IR (KBr): 1018, 1097 cm-¹ (C-O).
¹H NMR (400 MHz, CDCl3): δ = 0.85-1.10, 1.10-1.47, 1.50-1.85, 1.90-2.20 [4 m, 15 H, (CH2)5, CH 2CHCH 2, c-Hex CH2CHCH2], 2.75-2.95 (m, 1 H, CH2CHCH2), 3.61-3.97 (m, 3 H, CH2O, CHO), 5.70 (d, J = 5.0 Hz, 1 H, OCHO).
¹³C NMR (100 MHz, CDCl3): δ = 25.8, 26.0, 26.4, 28.8, 30.0 [(CH2)5], 32.8 (CH2CH2O), 36.5 (CH2 CHCH2), 68.2 (CH2O), 84.2 (CHO), 108.7 (OCHO).
MS (EI): m/z (%) = 196 [M+] (<1), 152 (10), 113 (100), 69 (37), 55 (13).
HRMS: m/z [M+] calcd for C12H20O2: 196.1463; found: 196.1432.
Selected data for the minor diastereomer (2S*,3aS*,6aR*)-10e:
GLC: t R = 12.45 min.
¹H NMR (400 MHz, CDCl3): δ = 5.62 (d, J = 5.5 Hz, 1 H, OCHO).
MS (EI): m/z (%) = 196 [M+] (<1), 113 (100), 69 (37), 55 (13).
(2 R *,3a S *,6a R *)-2-Phenylhexahydrofuro[2,3- b ]furan (10f) [8b]
Colorless oil; GLC: t R = 12.91 min; R f = 0.35 (hexane-EtOAc, 8:2).
IR (KBr): 3062, 3030, 1603, 1494 (CH=C), 1016 cm-¹ (C-O).
¹H NMR (400 MHz, CDCl3): δ = 1.80-1.90, 1.98-2.10, 2.14-2.30 (3 m, 4 H, CH 2CHCH 2), 2.97-3.09 (m, 1 H, CH2CHCH2), 3.91-4.10 (m, 2 H, CH2O), 5.12 (dd, J = 5.7, 5.0 Hz, 1 H, CHO), 5.93 (d, J = 4.9 Hz, 1 H, OCHO), 7.24-7.46 (m, 5 H, 5 ArH).
¹³C NMR (100 MHz, CDCl3): δ = 32.5 (CH2CH2O), 41.6 (CH2CHO), 43.0 (CH2 CHCH2), 68.4 (CH2O), 84.8 (CHO), 109.4 (OCHO), 125.7, 127.5, 128.4 (5 ArCH), 141.5 (ArC).
MS (EI): m/z (%) = 190 [M+] (10), 145 (10), 143 (10), 129 (38), 128 (15), 117 (13), 115 (17), 107 (20), 105 (21), 104 (21), 91 (22), 84 (100), 83 (19), 78 (10), 77 (22), 70 (27), 69 (14), 56 (15), 55 (20).
HRMS: m/z [M+] calcd for C12H14O2: 190.0994; found: 190.0989.
Selected data for the minor diastereomer (2S*,3aS*,6aR*)-10f:
GLC: t R = 12.45 min.
¹H NMR (400 MHz, CDCl3): δ = 5.81 (d, J = 5.5 Hz, 1 H, OCHO).
MS (EI): m/z (%) = 190 [M+] (6), 129 (31), 128 (16), 117 (11), 115 (16), 107 (21), 105 (21), 104 (22), 91 (21), 84 (100), 83 (19), 77 (22), 70 (22), 69 (14), 56 (15), 55 (20).
(3a R *,6a S *)-5,5-Diethyltetrahydrofuro[2,3- b ]furan-2(6a H )-one
Following a variant of a literature procedure for the oxidation of a tetrahydrofuran ring: [²³] Compound 10a (170 mg, 1 mmol) was slowly added to a soln of RuO2˙xH2O (27 mg) and NaIO4 (856 mg, 4 mmol) in CH2Cl2-H2O-MeCN (2:2:1, 5 mL). The mixture was stirred at r.t. for 6 h, followed by the addition of H2O (10 mL) and extraction with CH2Cl2 (3 × 10 mL). The combined organic extracts were dried (anhyd MgSO4), concentrated under vacuum (20 mbar), and purified by column chromatography (silica gel, hexane-EtOAc, 1:1) to give pure lactone 11a as a colorless oil; GLC: t R = 11.52 min; R f = 0.51 (hexane-EtOAc, 1:1).
IR (film): 1778 (C=O), 1116 cm-¹ (C-O).
¹H NMR (400 MHz, CDCl3): δ = 0.89 (2 t, 6 H, J = 7.5, Hz, 2 CH3), 1.50-1.75 (m, 5 H, 2 CH 2CH3, CH AHBCO), 2.19 (dd, J = 13.2, 9.9 Hz, 1 H, CHA H BCO), 2.49 (dd, J = 17.9, 1.3 Hz, 1 H, CH AHBCO2), 2.79 (dd, J = 17.9, 8.5 Hz, 1 H, CHA H BCO2), 3.07-3.18 (m, 1 H, CH2CHCH2), 6.01 (d, J = 5.1 Hz, 1 H, OCHO).
¹³C NMR (100 MHz, CDCl3): δ = 8.3, 8.5 (2 CH3), 31.1, 32.2 (2 CH2CH3), 36.5 (CH2CO2), 39.5 (CH2CO), 40.1 (CH2 CHCH2), 92.2 (CO), 109.1 (OCHO), 174.4 (CO2).
MS (EI): m/z (%) = 184 [M+] (<1), 155 [M+ - C2H5] (100), 137 (18), 127 (14), 112 (10), 111 (11), 109 (13), 97 (10), 96 (15), 81 (12), 70 (10), 69 (17), 57 (41), 55 (16).
HRMS: m/z [M+] calcd for C10H16O3: 184.1099; m/z [M+ - C2H5] calcd C8H11O3: 155.0703; found: 155.0737.
Acknowledgment
This work was generously supported by the Spanish Ministerio de Educación y Ciencia (MEC; grant no. CTQ2007-65218 and Consolider Ingenio 2010-CSD2007-00006) and the Generalitat Valenciana (grant no. PROMETEO/2009/039). D. S. and M. R.-F. thank the Vicerrectorado de Investigación, Desarrollo e Innovación of the University of Alicante for predoctoral and postdoctoral grants, respectively.
- 1a
Cardillo G.Contento M.Sandri S. Tetrahedron Lett. 1974, 15: 2215 - 1b
Carlson RM. Tetrahedron Lett. 1978, 19: 111 - 2a
Trost BM.Chan DMT. J. Am. Chem. Soc. 1981, 103: 5972 - 2b
Trost BM.Chan DMT.Nanninga TN. Org. Synth. Coll. Vol. VII John Wiley & Sons; London: 1990. p.266 - 3
Bigot A.Breit B. Synthesis 2008, 3692 - See, for instance:
- 4a
Chen H.Tan RX.Liu ZL.Zhang Y. J. Nat. Prod. 1996, 59: 668 - 4b
Boneva IM.Malakov PY.Papanov GY. Phytochemistry 1998, 47: 303 - 4c
Malakov PY.Papanov GY. Phytochemistry 1998, 49: 2443 - See, for instance:
- 5a
Malakov PY.Papanov GY.Boneva IM. Phytochemistry 1996, 41: 855 - 5b
de la Torre MC.Rodríguez B.Bruno B.Vassallo N.Bondì ML.Piozzi F.Servettaz O. J. Nat. Prod. 1997, 60: 1229 - 5c
Malakov PY.Papanov GY. Phytochemistry 1997, 46: 955 - 5d
Malakov PY.Papanov GY.Deltchev VB. Phytochemistry 1998, 49: 811 - 6a
Rodríguez B.de la Torre MC.Jimeno M.-L.Bruno M.Vassallo N.Bondì ML.Piozzi F.Servettaz O. J. Nat. Prod. 1997, 60: 348 - 6b
Malakov PY.Papanov GY. Phytochemistry 1998, 49: 2449 - 6c
Bruno M.Cruciata M.Bondì ML.Piozzi F.de la Torre MC.Rodríguez B.Servettaz O. Phytochemistry 1998, 48: 687 - 7
Rosselli S.Maggio A.Piozzi F.Simmonds MSJ.Bruno M. J. Agric. Food Chem. 2004, 52: 7867 ; and references cited therein - 8a
Kojima Y.Kato N. Tetrahedron 1981, 37: 2527 - 8b
klein Gebbinck EA.Bouwman CT.Bourgois M.Jansen BJM.de Groot A. Tetrahedron 1999, 55: 11051 - 9
Fukui H.Tsuchiya Y.Fujita K.Nakagawa T.Koshino H.Nakata T. Bioorg. Med. Chem. Lett. 1997, 7: 2081 - 10a
Kido F.Sinha SC.Abiko T.Watanabe M.Yoshikoshi A. J. Chem. Soc., Chem. Commun. 1990, 418 - 10b
Kido F.Sinha SC.Abiko T.Watanabe M.Yoshikoshi A. Tetrahedron 1990, 46: 4887 - 11a
Alonso F.Lorenzo E.Yus M. Tetrahedron Lett. 1997, 38: 2187 - 11b
Alonso F.Lorenzo E.Yus M. Tetrahedron Lett. 1998, 39: 3303 - 11c
Lorenzo E.Alonso F.Yus M. Tetrahedron Lett. 2000, 41: 1661 - 11d
Lorenzo E.Alonso F.Yus M. Tetrahedron 2000, 56: 1745 - 11e
Alonso F.Lorenzo E.Meléndez J.Yus M. Tetrahedron 2003, 59: 5199 - 11f
Alonso F.Meléndez J.Yus M. Russ. Chem. Bull. 2003, 52: 2628 - 11g
Alonso F.Meléndez J.Yus M. Tetrahedron Lett. 2005, 46: 6519 - 11h
Alonso F.Meléndez J.Yus M. Tetrahedron 2006, 62: 4814 - 12a
Alonso F.Falvello LR.Fanwick PE.Lorenzo E.Yus M. Synthesis 2000, 949 - 12b
Alonso F.Meléndez J.Yus M. Helv. Chim. Acta 2002, 85: 3262 - 12c
Alonso F.Meléndez J.Yus M. Tetrahedron Lett. 2004, 45: 1717 - 12d
Alonso F.Dacunha B.Meléndez J.Yus M. Tetrahedron 2005, 61: 3437 - 12e
Dacunha B.Alonso F.Meléndez J.Yus M. Acta Crystallogr., Sect. A 2005, 61: C157 - 12f
Meléndez J.Alonso F.Yus M. Tetrahedron Lett. 2006, 47: 1187 - 12g
Alonso F.Meléndez J.Soler T.Yus M. Tetrahedron 2006, 62: 2264 - 12h
Alonso F.Foubelo F.Yus M. Curr. Chem. Biol. 2007, 1: 317 - 12i
Alonso F.Meléndez J.Yus M. Synlett 2008, 1627 - 13
Alonso F.Sánchez D.Yus M. Adv. Synth. Catal. 2008, 350: 2118 - 14
Moreno-Dorado F.Guerra FM.Manzano FL.Aladro FJ.Jorge ZD.Massanet GM. Tetrahedron Lett. 2003, 44: 6691 - 15 For a review, see:
Yus M. Synlett 2001, 1197 - 16
Yong KH.Lotoski JA.Chong JM. J. Org. Chem. 2001, 66: 8248 - 17
Cardillo G.Contento M.Sandri S. J. Chem. Soc., Perkin Trans. 1 1979, 1729 - 18 For a review, see:
Cravotto G.Cintas P. Chem. Soc. Rev. 2006, 35: 180 - 19
Lecomte V.Stéphan E.Le Bideau F.Jaouen G. Tetrahedron 2003, 59: 2169 - 20
Streiff S.Ribeiro N.Désaubry L. Chem. Commun. 2004, 346 - 21
Stewart JJP. J. Comput. Chem. 1991, 12: 320 - 22 For a review, see:
Jung ME.Pizzi G. Chem. Rev. 2005, 105: 1735 - 23
Berkowitz WF.Amarasekara AS.Perumattam JJ.
J. Org. Chem. 1987, 52: 1119
References
- 1a
Cardillo G.Contento M.Sandri S. Tetrahedron Lett. 1974, 15: 2215 - 1b
Carlson RM. Tetrahedron Lett. 1978, 19: 111 - 2a
Trost BM.Chan DMT. J. Am. Chem. Soc. 1981, 103: 5972 - 2b
Trost BM.Chan DMT.Nanninga TN. Org. Synth. Coll. Vol. VII John Wiley & Sons; London: 1990. p.266 - 3
Bigot A.Breit B. Synthesis 2008, 3692 - See, for instance:
- 4a
Chen H.Tan RX.Liu ZL.Zhang Y. J. Nat. Prod. 1996, 59: 668 - 4b
Boneva IM.Malakov PY.Papanov GY. Phytochemistry 1998, 47: 303 - 4c
Malakov PY.Papanov GY. Phytochemistry 1998, 49: 2443 - See, for instance:
- 5a
Malakov PY.Papanov GY.Boneva IM. Phytochemistry 1996, 41: 855 - 5b
de la Torre MC.Rodríguez B.Bruno B.Vassallo N.Bondì ML.Piozzi F.Servettaz O. J. Nat. Prod. 1997, 60: 1229 - 5c
Malakov PY.Papanov GY. Phytochemistry 1997, 46: 955 - 5d
Malakov PY.Papanov GY.Deltchev VB. Phytochemistry 1998, 49: 811 - 6a
Rodríguez B.de la Torre MC.Jimeno M.-L.Bruno M.Vassallo N.Bondì ML.Piozzi F.Servettaz O. J. Nat. Prod. 1997, 60: 348 - 6b
Malakov PY.Papanov GY. Phytochemistry 1998, 49: 2449 - 6c
Bruno M.Cruciata M.Bondì ML.Piozzi F.de la Torre MC.Rodríguez B.Servettaz O. Phytochemistry 1998, 48: 687 - 7
Rosselli S.Maggio A.Piozzi F.Simmonds MSJ.Bruno M. J. Agric. Food Chem. 2004, 52: 7867 ; and references cited therein - 8a
Kojima Y.Kato N. Tetrahedron 1981, 37: 2527 - 8b
klein Gebbinck EA.Bouwman CT.Bourgois M.Jansen BJM.de Groot A. Tetrahedron 1999, 55: 11051 - 9
Fukui H.Tsuchiya Y.Fujita K.Nakagawa T.Koshino H.Nakata T. Bioorg. Med. Chem. Lett. 1997, 7: 2081 - 10a
Kido F.Sinha SC.Abiko T.Watanabe M.Yoshikoshi A. J. Chem. Soc., Chem. Commun. 1990, 418 - 10b
Kido F.Sinha SC.Abiko T.Watanabe M.Yoshikoshi A. Tetrahedron 1990, 46: 4887 - 11a
Alonso F.Lorenzo E.Yus M. Tetrahedron Lett. 1997, 38: 2187 - 11b
Alonso F.Lorenzo E.Yus M. Tetrahedron Lett. 1998, 39: 3303 - 11c
Lorenzo E.Alonso F.Yus M. Tetrahedron Lett. 2000, 41: 1661 - 11d
Lorenzo E.Alonso F.Yus M. Tetrahedron 2000, 56: 1745 - 11e
Alonso F.Lorenzo E.Meléndez J.Yus M. Tetrahedron 2003, 59: 5199 - 11f
Alonso F.Meléndez J.Yus M. Russ. Chem. Bull. 2003, 52: 2628 - 11g
Alonso F.Meléndez J.Yus M. Tetrahedron Lett. 2005, 46: 6519 - 11h
Alonso F.Meléndez J.Yus M. Tetrahedron 2006, 62: 4814 - 12a
Alonso F.Falvello LR.Fanwick PE.Lorenzo E.Yus M. Synthesis 2000, 949 - 12b
Alonso F.Meléndez J.Yus M. Helv. Chim. Acta 2002, 85: 3262 - 12c
Alonso F.Meléndez J.Yus M. Tetrahedron Lett. 2004, 45: 1717 - 12d
Alonso F.Dacunha B.Meléndez J.Yus M. Tetrahedron 2005, 61: 3437 - 12e
Dacunha B.Alonso F.Meléndez J.Yus M. Acta Crystallogr., Sect. A 2005, 61: C157 - 12f
Meléndez J.Alonso F.Yus M. Tetrahedron Lett. 2006, 47: 1187 - 12g
Alonso F.Meléndez J.Soler T.Yus M. Tetrahedron 2006, 62: 2264 - 12h
Alonso F.Foubelo F.Yus M. Curr. Chem. Biol. 2007, 1: 317 - 12i
Alonso F.Meléndez J.Yus M. Synlett 2008, 1627 - 13
Alonso F.Sánchez D.Yus M. Adv. Synth. Catal. 2008, 350: 2118 - 14
Moreno-Dorado F.Guerra FM.Manzano FL.Aladro FJ.Jorge ZD.Massanet GM. Tetrahedron Lett. 2003, 44: 6691 - 15 For a review, see:
Yus M. Synlett 2001, 1197 - 16
Yong KH.Lotoski JA.Chong JM. J. Org. Chem. 2001, 66: 8248 - 17
Cardillo G.Contento M.Sandri S. J. Chem. Soc., Perkin Trans. 1 1979, 1729 - 18 For a review, see:
Cravotto G.Cintas P. Chem. Soc. Rev. 2006, 35: 180 - 19
Lecomte V.Stéphan E.Le Bideau F.Jaouen G. Tetrahedron 2003, 59: 2169 - 20
Streiff S.Ribeiro N.Désaubry L. Chem. Commun. 2004, 346 - 21
Stewart JJP. J. Comput. Chem. 1991, 12: 320 - 22 For a review, see:
Jung ME.Pizzi G. Chem. Rev. 2005, 105: 1735 - 23
Berkowitz WF.Amarasekara AS.Perumattam JJ.
J. Org. Chem. 1987, 52: 1119
References

Figure 1

Figure 2

Scheme 1 Synthesis of 2,5-substituted perhydrofuro[2,3-b]furans through arene-catalyzed lithiation and Wacker-type reactions

Scheme 2 Preliminary synthesis of a 3-methylene-1,5-diol precursor of a 2-substituted perhydrofuro[2,3-b]furan

Scheme 3 Synthesis of allylsilanes 7 and 8 through conventional metalation conditions

Scheme 4 Synthesis of allylsilanes 7 and 8 through ultrasound-promoted dianion formation


Scheme 5 Reaction of isopentenyl alcohol dianion with various carbonyl compounds

Scheme 6 Cyclization of methylene diols 9 to perhydrofuro[2,3-b]furans 10 under Wacker-type conditions
















Figure 3 NOE experiments and optimized geometry models for the diastereomeric perhydrofuro[2,3-b]furans 10f; numbers on the arrows refer to interatomic distances in Å

Scheme 7 Comparative synthesis of perhydrofuro[2,3-b]furan 10e according to the literature approach [8b] and that described herein

Scheme 8 Oxidation of perhydrofuro[2,3-b]furan 10a to lactone 11a